Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Surg Neurol Int ; 11: 101, 2020.
Article in English | MEDLINE | ID: mdl-32494380

ABSTRACT

BACKGROUND: Granular cell tumor (GCT) of the sellar region is a rare tumor of the sellar and suprasellar regions that originate from the neurohypophysis. This tumor is very difficult to differentiate from other pituitary neoplasms, such as pituitary adenoma, pituicytoma, and spindle cell oncocytoma. We report a rare case of GCT arising from the posterior pituitary of the sellar region and suggest a useful indicator for accurate diagnosis and pitfalls for surgical procedures. CASE DESCRIPTION: A 42-year-old woman was admitted to our hospital with bitemporal hemianopsia. Neuroimaging showed a large pituitary tumor in the sellar and suprasellar regions with a hypointense part on T2-weighted magnetic resonance imaging, and the enhanced anterior pituitary gland was displaced anteriorly. Laboratory findings showed mild hyperprolactinemia. Subtotal resection of the tumor was achieved using an endoscopic endonasal transsphenoidal approach. Histological findings showed round or polygonal cells with abundant granular eosinophilic cytoplasm staining strongly for thyroid transcription factor 1. The tumor was, therefore, diagnosed as a GCT of the sellar region, belonging to tumors of the posterior pituitary. After surgery, visual impairment and anterior pituitary function were improved. Follow-up neuroimaging after 1 year showed no signs of recurrence. CONCLUSION: GCT of the sellar region is difficult to diagnose on routine neuroimaging. Therefore, accurate diagnosis requires careful identification of clinical signs, magnetic resonance imaging including hypointensity on T2-weighted imaging, and analysis of combined morphological and immunohistochemical studies.

2.
J Neuroimmunol ; 282: 7-20, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25903723

ABSTRACT

Two types of macrophages in lesion core of rat stroke model were identified according to NG2 chondroitin sulfate proteoglycan (NG2) and CD200 expression. NG2(+) macrophages were CD200(-), and vice versa. NG2(-) macrophages expressed two splice variants of CD200 that are CD200L and CD200S. CD200(+) macrophages expressed CD8, CD68, CD163, CCL2, inducible nitric oxide synthase, interleukin-1ß, Toll-like receptor 4 and transforming growth factor ß, whilst NG2(+) cells expressed a costimulatory factor CD86. Both cell types expressed insulin-like growth factor 1 and CD200R. These results demonstrate that the two macrophage types cannot be classified as either M1 or M2.


Subject(s)
Antigens, CD/metabolism , Brain/pathology , Gene Expression Regulation/physiology , Infarction, Middle Cerebral Artery/pathology , Macrophages/classification , Macrophages/metabolism , Animals , Antigens/metabolism , Antigens, CD/genetics , Bone Marrow Transplantation , Brain/metabolism , Calcium-Binding Proteins/metabolism , Cell Count , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Infarction, Middle Cerebral Artery/surgery , Insulin-Like Growth Factor I/metabolism , Ki-67 Antigen/metabolism , Male , Microfilament Proteins/metabolism , Nitric Oxide Synthase Type II/metabolism , Proteoglycans/metabolism , Rats , Rats, Sprague-Dawley , Rats, Transgenic , Rats, Wistar , Toll-Like Receptor 4/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL